p27(Kip1): A keg mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line

Oncogene

Volumn 16, Issue 25, 1998, Pages 3337-3343

  Matsuo, Tatsuya ^a   Thiele, Carol J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cdk; Cell cycle; G1 cyclin; N myc; Neuroblastoma; p27(Kip1); Retinoids

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; RETINOIC ACID; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; CELL CULTURE; CELL CYCLE; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEUROBLASTOMA; RNA, MESSENGER; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032565767     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201830     Document Type: Article

References (44)

1. Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB and Thiele CJ. (1995). Cancer Res., 55, 2380-2386.
2. Cushing H and Wollbach BB. (1927). Am. J. Pathol., 3, 203-215.
3. El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzer KW and Vogelstein B. (1993). Cell, 75, 817-825.
4. Gaetano C, Matsumoto K and Thiele CJ. (1991). Cell Growth & Diff., 2, 487-493.
5. Gaetano C, Matsumoto K and Thiele CJ. (1992). Cancer Res., 52, 4402-4407.
6. Gaetano C, Matsuo T and Thiele CJ. (1997). J. Biol. Chem., 272, 12195-12201.
7. Giannini G, Dawson MI, Zhang X and Thiele CJ. (1997). J. Biol. Chem., 272, 26693-26701.
8. Gu Y, Rosenblatt J and Morgan DO. (1992). EMBO J., 11, 3995-4005.
9. Gu Y, Turck CW and Morgan DO. (1993). Nature, 366, 707-710.
10. Hannon GJ and Beach D. (1994). Nature, 371, 257-261.
11. Harper JW, Adami GR, Wei K, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
12. Harvat BL, Seth P and Jetten AM. (1997). Oncogene, 14, 2111-2122.
13. Hengst L and Reed SI. (1996). Science, 271, 1861-1864.
14. Hirai H, Roussel MF, Kato J-Y, Ashmun RA and Sherr CJ. (1995). Mol. Cell. Biol., 15, 2672-2681.
15. Hoffman I, Draetta G and Karsenti E. (1994). EMBO J., 13, 4302-4310.
16. Iavarone A and Massague J. (1997). Nature, 387, 417-422.
17. Jinno S, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H and Okayama H. (1994). EMBO J., 13, 1549-1556.
18. Kaplan DR, Matsumoto K, Lucarelli E and Thiele CJ. (1993). Neuron, 11, 321-331.
19. Knudson Jr AG and Meadows AT. (1980). N. Engl. J. Med., 302, 1254-1256.
20. Kranenburg O, Scharnhost V, Van der Eb AJ and Zantema A. (1995). J. Cell Biol., 131, 227-234.
21. Liu M, Iavarone A and Freedman LP. (1996). J. Biol. Chem., 271, 31723-31728.
22. Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR and Thiele CJ. (1995). Cancer Res., 55, 1798-1806.
23. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato JA. (1994). Mol. Cell. Biol., 14, 2066-2076.
24. Morgan DO. (1995). Nature, 374, 131-134.
25. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR. (1994). Exp. Cell Res., 211, 90-98.
26. Ohtsubo M and Roberts JM. (1993). Science, 259, 1908-1912.
27. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF and Rolfe M. (1995). Science, 269, 682-685.
28. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Tempst P, Roberts JM and Massague J. (1994). Cell, 78, 59-66.
29. Quell DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF and Sherr CJ. (1993). Genes & Dev., 7, 1559-1571.
30. Resnitzky D, Gossen M, Bujard H and Reed SI. (1994). Mol. Cell. Biol., 14, 1669-1679.
31. Seewaldt VL, Kim JH, Caldwell LE, Johnson BS, Swisshelm K and Collons SJ. (1979). Cell Growth & Differ., 8, 631-641.
32. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
33. Sherr CJ. (1993). Cell, 73, 1059-1065.
34. Sherr CJ and Roberts JM. (1995). Genes & Dev., 9, 1149-1163.
35. Sidell NJ. (1982). J. Natl. Cancer Inst., 68, 589-593.
36. Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J and Eilers M. (1995). EMBO J., 14, 4814-4826.
37. Thaller C and Eichele G. (1987). Nature, 327, 625-628.
38. Thiele CJ, Reynolds CP and Israel MA. (1985). Nature, 313, 404-406.
39. Toyoshima H and Hunter T. (1994). Cell, 78, 67-74.
40. Vlach J, Hennecke S, Alevizopoulos K, Conti D and Amati B. (1996). EMBO J., 15, 6595-6604.
41. Wang QM, Jones JB and Studzinski GP. (1996). Cancer Res., 56, 264-267.
42. Wenzel A, Cziepluch C, Hamann U, Schrmann J and Schwab M. (1991). EMBO J., 12, 3703-3712.
43. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701-704.
44. Zhou Q, Stetler-Stevenson M and Steeg PS. (1997). Oncogene, 15, 107-115.